Sarcopenic Obesity in Osteoarthritis vs Rheumatoid Arthritis
Individuals with osteoarthritis may exhibit a higher prevalence of sarcopenic obesity, compared with patients with rheumatoid arthritis.
RA Year In Review 2017
Pneumococcal Vaccination in Patients With Rheumatoid Arthritis: Taking Treatment Into Consideration
Clinicians conducting pneumococcal vaccination in patients with rheumatoid arthritis should take into consideration the type of RA treatment being used and offer early vaccination.
Temporary Methotrexate Discontinuation Improves Influenza Vaccine Immunogenicity in RA
Temporary methotrexate discontinuation after receiving seasonal influenza vaccination improves the immunogenicity of vaccination in patients with rheumatoid arthritis.
TNFi Use Not Associated With Increased Cancer Risk in RA
Patients with rheumatoid arthritis who receive TNF inhibitor treatment do not appear to be at increased risk for overall cancer.
Ultrasound Scoring System for Evaluation of Synovitis of Wrists and Hands in RA
A simplified and validated ultrasound scoring system for the evaluation of synovitis in the wrists and hands of patients with rheumatoid arthritis has been proposed.
Assessment of Intracranial Circulation in Rheumatoid Arthritis
This study appears to be the first of its kind to use transcranial Doppler to assess intracranial arteries in rheumatoid arthritis.
Patients With RA Using DMARDs May Have Higher Risk for Dementia
These results highlight the importance of a multidisciplinary team for treating patients with rheumatoid arthritis.
Predictive Value of Autoantibodies in Clinically Suspect Arthralgia and Risk for RA
The presence of the certain autoantibodies accurately predicts a person’s risk for progression from clinically suspect arthralgia to rheumatoid arthritis.
Tapering TNF Inhibitors: A Good Strategy for Rheumatoid Arthritis?
Lowering tumor necrosis factor inhibitor dosage by one-third yielded excellent results in terms of safety, clinical effectiveness, and tolerability in patients with rheumatoid arthritis.
JAK-1 Inhibitor Filgotinib Efficacious, Safe for Rheumatoid Arthritis in Phase IIa Trial
The selective Janus kinase-1 inhibitor filgotinib has shown initial efficacy and adequate safety for the treatment of rheumatoid arthritis.
Next post in Rheumatoid Arthritis
